Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. Politz
Copanlisib Synergies With Conventional and Targeted Agents Including Venetoclax in Preclinical Models of B- And T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combinatorial Screening of the Pi3k Inhibitor Copanlisib in T Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Venetoclax Synergizes With Radiotherapy for Treatment of B-Cell Lymphomas
Cancer Research
Cancer Research
Oncology
Clinical Outcomes From Venetoclax Based Therapy in Patients With Relapsed/Refractory B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Evolving Role of Targeted Biological Agents in the Management of Indolent B-Cell Lymphomas
Therapeutic Advances in Hematology
Hematology
In Vitro Demonstration of Synergism With Pixantrone Combined With Targeted Agents in Lymphomas
British Journal of Haematology
Hematology
Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy
American Journal of Hematology
Hematology
Copanlisib and Volasertib Overcome Ibrutinib-Venetoclax Resistance via Targeting Pi3k-Akt Signaling and G2/M Cell Cycle Transition in Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cell Cycle Deregulation in B-Cell Lymphomas
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The BTK Inhibitor Zanubrutinib (BGB-3111) Demonstrated Synergies With Other Anti-Lymphoma Targeted Agents
Haematologica
Hematology
